These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 2467670)

  • 1. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C.
    Kobayashi E; Nakano H; Morimoto M; Tamaoki T
    Biochem Biophys Res Commun; 1989 Mar; 159(2):548-53. PubMed ID: 2467670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calphostin (UCN1028) and calphostin related compounds, a new class of specific and potent inhibitors of protein kinase C.
    Tamaoki T; Takahashi I; Kobayashi E; Nakano H; Akinaga S; Suzuki K
    Adv Second Messenger Phosphoprotein Res; 1990; 24():497-501. PubMed ID: 1698411
    [No Abstract]   [Full Text] [Related]  

  • 3. Potent and specific inhibitors of protein kinase C of microbial origin.
    Tamaoki T; Nakano H
    Biotechnology (N Y); 1990 Aug; 8(8):732-5. PubMed ID: 1370017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UCN-1028A, a novel and specific inhibitor of protein kinase C, from Cladosporium.
    Kobayashi E; Ando K; Nakano H; Tamaoki T
    J Antibiot (Tokyo); 1989 Jan; 42(1):153-5. PubMed ID: 2466029
    [No Abstract]   [Full Text] [Related]  

  • 5. Calphostins (UCN-1028), novel and specific inhibitors of protein kinase C. I. Fermentation, isolation, physico-chemical properties and biological activities.
    Kobayashi E; Ando K; Nakano H; Iida T; Ohno H; Morimoto M; Tamaoki T
    J Antibiot (Tokyo); 1989 Oct; 42(10):1470-4. PubMed ID: 2478514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of protein kinase C by calphostin C is light-dependent.
    Bruns RF; Miller FD; Merriman RL; Howbert JJ; Heath WF; Kobayashi E; Takahashi I; Tamaoki T; Nakano H
    Biochem Biophys Res Commun; 1991 Apr; 176(1):288-93. PubMed ID: 1708246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion analysis of protein kinase C inactivation by calphostin C.
    Rotenberg SA; Huang MH; Zhu J; Su L; Riedel H
    Mol Carcinog; 1995 Jan; 12(1):42-9. PubMed ID: 7529505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor agents. 134. New shiraiachrome-A- and calphostin-C-related perylene derivatives as cytotoxic and antiviral agents and inhibitors of protein kinase C.
    Wang HK; Xie JX; Chang JJ; Hwang KM; Liu SY; Ballas LM; Jiang JB; Lee KH
    J Med Chem; 1992 Jul; 35(15):2717-21. PubMed ID: 1379638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protein kinase C inhibitor, calphostin C, inhibits succinate-dependent mitochondrial reduction of MTT by a mechanism that does not involve protein kinase C.
    Berridge MV; Tan AS
    Biochem Biophys Res Commun; 1992 Jun; 185(3):806-11. PubMed ID: 1378266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase.
    Tamaoki T; Nomoto H; Takahashi I; Kato Y; Morimoto M; Tomita F
    Biochem Biophys Res Commun; 1986 Mar; 135(2):397-402. PubMed ID: 3457562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis of vascular smooth muscle cells. Protein kinase C and oncoprotein Bcl-2 are involved in regulation of apoptosis in non-transformed rat vascular smooth muscle cells.
    Leszczynski D; Zhao Y; Luokkamäki M; Foegh ML
    Am J Pathol; 1994 Dec; 145(6):1265-70. PubMed ID: 7527616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of staurosporine and calphostin C, two structurally unrelated inhibitors of protein kinase C, on vascular tone.
    Henrion D; Laher I
    Can J Physiol Pharmacol; 1993 Jul; 71(7):521-4. PubMed ID: 7694783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use and specificity of staurosporine, UCN-01, and calphostin C as protein kinase inhibitors.
    Tamaoki T
    Methods Enzymol; 1991; 201():340-7. PubMed ID: 1719345
    [No Abstract]   [Full Text] [Related]  

  • 14. Calphostin-C stimulates epidermal growth factor receptor phosphorylation and internalization via light-dependent mechanism.
    Gamou S; Shimizu N
    J Cell Physiol; 1994 Jan; 158(1):151-9. PubMed ID: 7505275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of inhibitors of protein kinase C and calpain in experimental delayed cerebral vasospasm.
    Minami N; Tani E; Maeda Y; Yamaura I; Fukami M
    J Neurosurg; 1992 Jan; 76(1):111-8. PubMed ID: 1370069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calphostins, novel and specific inhibitors of protein kinase C. II. Chemical structures.
    Iida T; Kobayashi E; Yoshida M; Sano H
    J Antibiot (Tokyo); 1989 Oct; 42(10):1475-81. PubMed ID: 2478515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calphostin C, a specific protein kinase C inhibitor, activates human neutrophils: effect on phospholipase A2 and aggregation.
    Svetlov S; Nigam S
    Biochim Biophys Acta; 1993 May; 1177(1):75-8. PubMed ID: 7683494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation.
    Courage C; Budworth J; Gescher A
    Br J Cancer; 1995 Apr; 71(4):697-704. PubMed ID: 7710931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C.
    Jarvis WD; Turner AJ; Povirk LF; Traylor RS; Grant S
    Cancer Res; 1994 Apr; 54(7):1707-14. PubMed ID: 7511048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible role of protein kinase C-epsilon isoenzyme in inhibition of interleukin 1 beta induction of nitric oxide synthase in rat renal mesangial cells.
    Mühl H; Pfeilschifter J
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):607-12. PubMed ID: 7526844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.